JMVSX | JVMCX | JMVSX / JVMCX | |
Total Expense Ratio | 0.84 | 1.87 | 45% |
Annual Report Gross Expense Ratio | 0.94 | 1.88 | 50% |
Fund Existence | 24 years | 14 years | - |
Gain YTD | 0.222 | 3.123 | 7% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 1000 | 100,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 12.6B | 21.8B | 58% |
Annual Yield % from dividends | 0.87 | 0.00 | - |
Returns for 1 year | -3.78 | -5.78 | 66% |
Returns for 3 years | -1.24 | 9.69 | -13% |
Returns for 5 years | 25.76 | 54.86 | 47% |
Returns for 10 years | 1.03 | 25.15 | 4% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IBTH | 22.35 | -0.01 | -0.04% |
iShares iBonds Dec 2027 Term Tr ETF | |||
DFCA | 49.09 | -0.07 | -0.14% |
Dimensional California Municipal Bd ETF | |||
BWG | 8.16 | -0.03 | -0.37% |
BrandywineGLOBAL Global Income Opportunities Fund | |||
FEIG | 40.01 | -0.35 | -0.86% |
FlexShares ESG&Clmt Invm Grd Corp Cr Idx | |||
WDNA | 12.32 | -0.41 | -3.23% |
WisdomTree BioRevolution ETF |